AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28225506
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg IV ibuprofen in 100 mL saline
Trial: 26188456
Drug: Increased social
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased social control treatment (participants played in randomly assigned pairs of two)
Trial: 26188456
Drug: Baseline treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline treatment (subjects rolled a die in private)
Trial: 23004005
Drug: Peironimev‐plus/oral/one tablet‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peironimev‐plus/oral/one tablet‐daily + Verapamil injection (peri‐lesional) 10 mg/every two weeks + Verapamil iontophoresis/5 mg/three times a week for 6 months
Trial: 23004005
Drug: Verapamil injection
RxNorm normalized name: verapamil Injection
DrugBank: Verapamil (DB00661)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Verapamil injection (peri‐lesional) 10 mg/every two weeks + Verapamil iontophoresis/5 mg/three times a week for 6 months
Trial: 21940760
Drug: CX717 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CX717 1000 mg
Trial: 8080670
Drug: Dipyrone 1
RxNorm normalized name: dipyrone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone 1 g every 8 h (n = 41)
Trial: 8080670
Drug: Dipyrone 2
RxNorm normalized name: dipyrone 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone 2 g every 8 h (n = 38)
Trial: 8080670
Drug: Morphine 10
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 10 mg every 4 h (n = 42)
Trial: 8080670
Drug: Dipyrone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone (1 g or 2 g)
Trial: 2583144
Drug: All beverage
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All beverage treatments
Trial: 338198
Drug: Elevated levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated levels of antibodies to milk proteins in infants fed cow milk.
Trial: 28526210
Drug: Montelukast 4
RxNorm normalized name: montelukast 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 4 mg daily for 48 weeks
Trial: 28526210
Drug: As-needed β2-agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: As-needed β2-agonists
Trial: 22503005
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml increase in dead space through a custom designed full face mask
Trial: 16299869
Drug: Videotape and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Videotape and brochure with practical skills for self-control and treatment
Trial: 12571210
Drug: Radioiodine (RAI)
RxNorm normalized name: Radioiodine
DrugBank: Iodide I-131 (DB09293)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine (RAI) administered at a dose of 12,580 kBq/mL of nodular volume (NV)
Trial: 12571210
Drug: Percutaneous ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Percutaneous ethanol injection (PEI) followed by radioiodine (RAI)
Trial: 10353578
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg of budesonide Turbuhaler administered twice daily
Trial: 10353578
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg of budesonide Turbuhaler administered twice daily
Trial: 8575948
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (21 mg to 14 mg to 7 mg, each for 30 days)
Trial: 1680600
Drug: Propranolol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.15 mg kg‐1 i.v.) during exercise
Trial: 6989437
Drug: Advice on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advice on dietary reduction of plasma cholesterol, smoking cessation, regular exercise, reduced energy intake for overweight, and hypertension treatment.
Trial: 7964913
Drug: Intranasal sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal sumatriptan 20 mg
Trial: 3105506
Drug: Transdermal Trinitrin
RxNorm normalized name: Trinitrine
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal Trinitrin (10 mg per 24 hours)
Trial: 30863047
Drug: Glycopyrrolate (GLY)
RxNorm normalized name: Glycopyrrolate
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate (GLY) 15.6 µg twice daily
Trial: 15836660
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg atorvastatin + placebo alpha‐tocopherol
Trial: 15836660
Drug: 800 IU
RxNorm normalized name: Vitamin E 800 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 IU alpha‐tocopherol + placebo atorvastatin
Trial: 15836660
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg atorvastatin + 800 IU alpha‐tocopherol
Trial: 15836660
Drug: placebo atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo atorvastatin + placebo alpha‐tocopherol
Trial: 11888030
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of risedronate sodium
Trial: 30396440
Drug: Exposure to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure to bacteria through cultural practices (e.g., consumption of unboiled milk, access to water sources)
Trial: 24568360
Drug: Continuous positive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous positive airway pressure treatment for four weeks
Trial: 24568360
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual for four weeks
Trial: 20188795
Drug: L/S' genotype
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L/S' genotype
Trial: 12397459
Drug: High-dose radioiodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radioiodine therapy (at least 2.96 GBq iodine-131, maximal administered activity 22.3 GBq)
Trial: 12397459
Drug: High-dose radioiodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radioiodine therapy
Trial: 15490777
Drug: Bonding agent/composite
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bonding agent/composite combination (Prime & Bond 2.1/PrismaTPH)
Trial: 7646610
Drug: Paracervical block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracervical block with 10 mL of 1% mepivacaine hydrochloride solution (n = 87)
Trial: 4719668
Drug: Alum-precipitated M
RxNorm normalized name: Precipitated Sulfur
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alum-precipitated M protein vaccine
Trial: 105114
Drug: 0.1 unit/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 unit/kg regular insulin given intramuscularly every two hours
Trial: 105114
Drug: 1.0 unit/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 unit/kg regular insulin given half subcutaneously and half intravenously every 4 hours
Trial: 29648726
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of alendronate sodium (70 mg)
Trial: 29648726
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of alendronate sodium (70 mg)
Trial: 19640384
Drug: Plasma von
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma von Willebrand factor and soluble vascular adhesion molecule-1
Trial: 15167309
Drug: 17beta‐estradiol 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta‐estradiol 2 mg + norethisterone acetate 1 mg (E2/NETA)
Trial: 15167309
Drug: Raloxifene HCL
RxNorm normalized name: raloxifene HCl
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Raloxifene HCL 60 mg
Trial: 12518494
Drug: Discus Dental
RxNorm normalized name: Sus scrofa intervertebral disc preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discus Dental Zoom! Chairside System (25% hydrogen peroxide whitening gel)
Trial: 12518494
Drug: Opalescence Xtra
RxNorm normalized name: benzocaine
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Opalescence Xtra Boost Kit (38% hydrogen peroxide whitening gel)
Trial: 9811286
Drug: Garlic extract
RxNorm normalized name: Garlic Extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic extract (Kwai, 300 mg, 3 times a day)
Trial: 7815239
Drug: High‐dose corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High‐dose corticosteroids
Trial: 2576361
Drug: Picumast dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picumast dihydrochloride 2 mg/d
Trial: 2576361
Drug: Picumast dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picumast dihydrochloride 4 mg/d
Trial: 27881709
Drug: Metformin use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin use in patients with diabetes mellitus (n = 115)
Trial: 27881709
Drug: Non-users of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-users of metformin (DM patients without metformin use and non-DM patients)
Trial: 20163275
Drug: Rotigotine transdermal
RxNorm normalized name: Rotigotine Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine transdermal patch (1 to 3 mg/24 h)
Trial: 8626365
Drug: Nefazodone, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefazodone, 100 mg b.i.d. starting dose, adjusted to 300-500 mg daily
Trial: 1425394
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g dextrose
Trial: 2866168
Drug: Sinemet (L-DOPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sinemet (L-DOPA plus carbidopa) with haloperidol
Trial: 26409030
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg sublingual buprenorphine
Trial: 20617288
Drug: Fosinopril (ACE-inhibitor)
DrugBank: Fosinopril (DB00492)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosinopril (ACE-inhibitor) for 6 months
Trial: 17852925
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (r-hGH) 4 mg daily
Trial: 12450890
Drug: Lactobacillus plantarum
RxNorm normalized name: Lactobacillus Plantarum
DrugBank: Lactobacillus plantarum (DB11360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus plantarum 299v (5 x 10(7) colony-forming units/mL) in a rose-hip drink, 400 mL/d for 6 weeks
Trial: 12450890
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (rose-hip drink without bacteria), 400 mL/d for 6 weeks
Trial: 8630585
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (NO) at 17.8 ± 2.7 ppm
Trial: 1746300
Drug: Physician-administered genogram
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physician-administered genogram (PAGE)
Trial: 1746300
Drug: Self-administered genogram
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered genogram (SAGE)
Trial: 19678927
Drug: Breast Conservative
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast Conservative Therapy (BCT)
Trial: 15880962
Drug: Sorbitol (G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorbitol (G group)
Trial: 12458352
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (before neuraminidase inhibitors)
Trial: 9792309
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (AmBisome, 5 mg/kg/d)
Trial: 9792309
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B deoxycholate (AmB, 1 mg/kg/d)
Trial: 6330425
Drug: Zinc therapy
RxNorm normalized name: PYRITHIONE ZINC 2 g in 100 g TOPICAL SOAP [Zinc Therapy]
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc therapy using a nonproprietary zinc dialysate
Trial: 25245767
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (IVL) - 2% intravenously (1.5 mg/kg bolus, 2 mg/kg/h infusion)
Trial: 25245767
Drug: Lumbar epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumbar epidural lidocaine analgesia (LEA) - lidocaine epidurally (1.5 mg/kg bolus, 2 mg/kg/h infusion)
Trial: 22234019
Drug: Intravenous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous low-dose ketamine (0.1 mg/kg as a preincisional bolus followed by a continuous infusion of 0.05 mg/kg/h)
Trial: 9613405
Drug: Felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5 mg administered the evening and morning before surgery
Trial: 8512909
Drug: Intramuscular and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular and oral ketorolac
Trial: 3450519
Drug: Nifedipine therapy
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine therapy for 2 and 14-16 weeks
Trial: 25491116
Drug: 0.05% desonide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% desonide cream
Trial: 18257177
Drug: Prozac (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prozac (20 mg/d)
Trial: 15678251
Drug: Topical liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical liposomal heparin spraygel (LHSG) (Lipohep Forte Spraygel, 4 puffs of 458 IU tid, n = 22)
Trial: 15678251
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH) (Clexane 40 mg once a day, n = 24)
Trial: 12790214
Drug: Hyperbaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric bupivacaine 10 mg + neostigmine 25 microg in dextrose 5%, 1 mL, total volume 3 mL (Group 2)
Trial: 12790214
Drug: Hyperbaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric bupivacaine 10 mg + neostigmine 50 microg in dextrose 5%, 1 mL, total volume 3 mL (Group 3)
Trial: 12790214
Drug: Hyperbaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric bupivacaine 10 mg + dextrose 5%, 1 mL, total volume 3 mL (Group 1)
Trial: 10376255
Drug: 0.5% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% timolol maleate in gel-forming solution
Trial: 3900727
Drug: Intramuscular lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular lidocaine (400 mg)
Trial: 23008301
Drug: Short-course (SC)
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course (SC) radiotherapy: 5 × 5 Gy in 1 week, early surgery, and six courses of adjuvant chemotherapy
Trial: 23008301
Drug: Long-course (LC)
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-course (LC) chemoradiation: 50.4 Gy, 1.8 Gy/fraction, in 5.5 weeks, with continuous infusional fluorouracil 225 mg/m(2) per day, surgery in 4 to 6 weeks, and four courses of chemotherapy
Trial: 19859670
Drug: Advanced Standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced Standard Treatment (AST) - rheological therapy complemented by distraction and relaxation training
Trial: 19859670
Drug: Standard Treatment
RxNorm normalized name: Azo-Standard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard Treatment (ST) - rheological therapy
Trial: 17931375
Drug: 10 seconds
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10 seconds injection duration
Trial: 17931375
Drug: 30 seconds
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 30 seconds injection duration
Trial: 15950671
Drug: Extended transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended transdermal contraception (ORTHO EVRA) used in an extended regimen (84 days)
Trial: 15046711
Drug: Liposomal doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal doxorubicin 50 mg/m2
Trial: 15046711
Drug: Doxorubicin 50
RxNorm normalized name: DOXOrubicin 50 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 50 mg/m2 (first dose only)
Trial: 15046711
Drug: Liposomal doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal doxorubicin 50 mg/m2 (subsequent cycles)
Trial: 7572056
Drug: Antiepileptic drugs
RxNorm normalized name: ANTIEPILEPTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiepileptic drugs (AED) treatment (carbamazepine, oxcarbazepine, sodium‐valproate, phenobarbital, phenytoin)
Trial: 7572056
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of AED monotherapy (carbamazepine or sodium‐valproate)
Trial: 7572056
Drug: Switch from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch from phenytoin to carbamazepine monotherapy
Trial: 2338113
Drug: Renzapride 2
RxNorm normalized name: Renzapride
DrugBank: Renzapride (DB04917)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renzapride 2 mg
Trial: 2338113
Drug: Renzapride 5
RxNorm normalized name: Renzapride
DrugBank: Renzapride (DB04917)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renzapride 5 mg
Trial: 2338113
Drug: Renzapride 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renzapride 0.2 to 5 mg
Trial: 320930
Drug: Methyltestosterone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyltestosterone (10 mg daily in linguet form)
Trial: 30535714
Drug: Submucosal autologous
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Submucosal autologous platelet-rich plasma injection (PRP injection group)
Trial: 30535714
Drug: Submucosal normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Submucosal normal saline injection (control group)
Trial: 28486595
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg ITM
Trial: 28486595
Drug: 200 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg ITM
Trial: 28486595
Drug: Choice of
RxNorm normalized name: HYDROGEN PEROXIDE 30 mg in 1 mL TOPICAL LIQUID [MediChoice of Hydrogen Peroxide 3 10 Volume]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choice of ITM dose (either 100 or 200 μg)
Trial: 23009581
Drug: Regular radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular radiation therapy
Trial: 17982752
Drug: Antioxidant therapy
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant therapy (NAC 600 mg and vitamins-minerals)
Trial: 17982752
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no adjunctive medical therapy)
Trial: 12950526
Drug: d,l‐sotalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d,l‐sotalol
Trial: 10392481
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg twice a day
Trial: 8912765
Drug: Rifampicin (RMP)
RxNorm normalized name: rifampicin
DrugBank: Rifampin (DB01045)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifampicin (RMP) 600 mg/d
Trial: 8912765
Drug: Rifabutin (RBT)
RxNorm normalized name: Rifabutin
DrugBank: Rifabutin (DB00615)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifabutin (RBT) 300 mg/d
Trial: 1652386
Drug: Intravenous and
RxNorm normalized name: immune globulin intravenous and subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous and subcutaneous salmon calcitonin
Trial: 7046707
Drug: Argon laser
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon laser photocoagulation treatment group
Trial: 28371488
Drug: Innovative film‐coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Innovative film‐coated warfarin sodium tablets
Trial: 28371488
Drug: Marketed sugar‐coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marketed sugar‐coated warfarin sodium tablets
Trial: 21968280
Drug: Relaxation training
RxNorm normalized name: Relax-DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxation training program (mini mp3 player with 13-min relaxation audio program, followed daily)
Trial: 14762496
Drug: Midazolam (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (1.0 mg/kg)
Trial: 14762496
Drug: Midazolam (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.75 mg/kg) plus Hydroxyzine (2.0 mg/kg)
Trial: 8846278
Drug: Continuous Morphine
RxNorm normalized name: morphine sulfate Oral Suspension [MST Continus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Morphine Infusion (CMI)